The soluble receptor for advanced glycation end-products (RAGE) and SARS-CoV-2 nucleocapsid viral antigen are two biomarkers recently shown to have prognostic value in hospitalized patients with COVID-19 (12–14). This evidence concerns the gene AGER and COVID-19.